Seres Therapeutics

Global pharmaceutical giant Pfizer (NYSE: PFE) and venture capital firm Flagship Pioneering have this week announced a joint commitment to invest USD 50 million each into the development of 10 drug candidates. Pfizer retains the option to acquire these candidates, while Flagship stands to collect up to USD 700 million…